Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Nyse  >  CIGNA Corporation    CI

SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsSector newsTweets

Cigna To Buy Great American Supplemental Benefits For $295 Million

share with twitter share with LinkedIn share with facebook
share via e-mail
0
05/11/2012 | 12:28am CEST

Cigna Corp. (>> CIGNA Corporation) has agreed to acquire American Financial Group Inc.'s (AFG) Medicare supplement and critical-illness businesses for approximately $295 million in cash, as the managed-care company looks to expand its presence in the individual and seniors markets.

Cigna said its acquisition of Great American Supplemental Benefits Group, one of the largest manufacturers of supplemental health insurance products in the U.S., is expected to close in the second half of 2012.

Great American generated approximately $325 million of revenue last year.

Cigna said the acquisition will expand its individual supplemental offerings to customers in the U.S., bring scaled offerings to the seniors market and extend its direct-to-consumer retail channel.

The deal comes after Cigna bought Medicare carrier HealthSpring Inc. in January for $3.8 billion. The HealthSpring acquisition represented a change in the balance of Cigna, which had primarily focused on employers but will now also be a major source of both Medicare prescription-drug plans and Medicare Advantage coverage, the private insurers' version of the government program.

Cigna has seen its revenue grow in recent quarters, helped by growing membership and a continuing trend of patients using fewer health-care services amid a shaky economy. Last week, the company reported its first-quarter earnings fell 10%, due in part to acquisition costs, though membership growth contributed to better-than-expected revenue.

Meanwhile, American Financial said the deal is expected to be slightly dilutive to its earnings in the short term but will help the company focus on its core businesses.

Cigna shares were up by 11 cents to $45.02 after hours. The stock is up 6.9% so far this year.

-By Nathalie Tadena, Dow Jones Newswires; 212-416-3287; [email protected]

Stocks mentioned in the article : CIGNA Corporation
share with twitter share with LinkedIn share with facebook
share via e-mail
0
Latest news on CIGNA CORPORATION
10/19 CIGNA CORPORATION (NYSE : CI) Files An 8-K Departure of Directors or Certain Off..
10/18 CIGNA CORP : Change in Directors or Principal Officers, Financial Statements and..
10/18 CIGNA FOUNDATION : and Ghetto Film School Announce Winners of Filmmaking Competi..
10/18DJHealth Insurers Step Up Open Enrollment Push As Window to Sign Up Shrinks
10/16 CIGNA-HEALTHSPRING : ’s Medicare Advantage Plans for 2018 Emphasize Afford..
10/11DJCompanies Ask Supreme Court to Hear Gay-Rights Case
10/10 CIGNA : Delta Dental of Virginia names new president
10/04 CIGNA IS COMMITTED TO REDUCING OPIOI : Removing OxyContin from Group Commercial ..
10/04 CIGNA CORPORATION : ’s Third Quarter 2017 Earnings Release Details
10/03 CIGNA : Assists People Affected by Las Vegas Shooting With Free 24x7 Telephone H..
More news
News from SeekingAlpha
10/19 Bipartisan bill to shore up ACA gaining support, 12 Republicans on board
10/18 Trump not on board with bipartisan Senate deal on Obamacare, bill stalled
10/18 UnitedHealth Faces 50% Share Drop Or Worse
10/17 Healthcare sector on the move after Senate deal
10/17 Premarket analyst action - healthcare
Financials ($)
Sales 2017 41 059 M
EBIT 2017 3 456 M
Net income 2017 2 425 M
Debt 2017 417 M
Yield 2017 0,01%
P/E ratio 2017 20,44
P/E ratio 2018 17,78
EV / Sales 2017 1,18x
EV / Sales 2018 1,16x
Capitalization 48 195 M
Chart CIGNA CORPORATION
Duration : Period :
CIGNA Corporation Technical Analysis Chart | CI | US1255091092 | 4-Traders
Technical analysis trends CIGNA CORPORATION
Short TermMid-TermLong Term
TrendsNeutralBullishBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 16
Average target price 196 $
Spread / Average Target 2,6%
EPS Revisions
Managers
NameTitle
David Michael Cordani President, Chief Executive Officer & Director
Isaiah Harris Chairman
Eric Palmer Chief Financial Officer
Alan M. Muney Chief Medical Officer
Mark L. Boxer Global Chief Information Officer & Executive VP
Sector and Competitors
1st jan.Capitalization (M$)
CIGNA CORPORATION43.50%48 195
UNITEDHEALTH GROUP29.65%200 614
AETNA INC29.70%53 415
ANTHEM INC35.42%51 123
HUMANA INC20.48%35 524
CENTENE CORP70.77%16 644